Company Overview of Meridian Life Science, Inc.
Meridian Life Science, Inc. manufactures and supplies antibodies, viral antigens, and critical assay reagents. The company’s product lines include animal sera, apoptosis and signal transduction, assay detection and other reagents, autoimmune reagents, bone and calcium metabolism, cancer research, cardiac markers, CD markers, collagen and extracellular matrix, cytokines and growth factors, cytoskeletal filaments and interstitial proteins, drug antibodies, enzymes, flow cytometry isotypic controls and blood lysing kit, hormones and steroids, immunoglobulin, animal, immunoglobulins, human, infectious diseases and toxins, lipoproteins, major histocompatibility antibodies, neuroscience reagents, ...
3471 River Hills Drive
Cincinnati, OH 45244
Founded in 1983
Key Executives for Meridian Life Science, Inc.
Director of Marketing and Business Development
Vice President of Research and Development
Compensation as of Fiscal Year 2015.
Meridian Life Science, Inc. Key Developments
Meridian Life Science, Inc. Opens New Office in Beijing, China
Jan 9 15
Meridian Bioscience, Inc. announced that Meridian Life Science, Inc. has opened a new office in Beijing, China. The office is located on Chang-An Avenue (close to Tiananmen Square and government offices) on the 15th floor in the New China Life Insurance (NCI) Tower Center, in the heart of the central business district (CBD) of Beijing.
Meridian Life Science Receives SBIR II by Centers for Disease Control and Prevention to Develop Rotavirus Vaccine
Dec 2 14
Meridian Life Science, Inc. announced that they have been selected by the Centers for Disease Control and Prevention (CDC) to develop a process for manufacture of a rotavirus vaccine. Funding for this activity will be provided through a Small Business Innovation Research (SBIR) contract. Process development will focus on optimization of growth and yield of the virus in cell culture, developing and characterizing a column-based purification process followed by formulation, inactivation and filling of the vaccine. This SBIR II, which follows an initial SBIR I awarded to MLS in 2013, will fund a 15 month research and development effort leading to scale up and manufacture of a rotavirus vaccine for use in clinical trials.
Meridian Life Science, Inc. Presents at 2013 BIO Convention in China, Nov-11-2013
Nov 11 13
Meridian Life Science, Inc. Presents at 2013 BIO Convention in China, Nov-11-2013 . Venue: China National Convention Center, No.7 Tianchen East Road, Chaoyang District, Beijing 100105, China.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|